Nonmedical Prescription Drug Use

  • David E. Smith
  • Richard B. Seymour


When we speak of drug abuse, we usually think of illicit drugs such as heroin, psychedelics, phencyledine, or marijuana—substances grown or manufactured illicitly and distributed to their consumers by some criminal network. In truth, many of the drugs that are used and abused have been manufactured by legitimate pharmeceutical houses.


Psychoactive Drug Substance Abuse Disorder Compulsive Drug Withdrawal Seizure Stimulant Abuse 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    American Psychiatric Association: Diagnostic and statistical manual of mental disorders (DSM-III), 3rd ed. APA, Washington, DC, 1980.Google Scholar
  2. 2.
    Griffith JS, Cavanaugh J, Oates J: Schizophreniform psychosis induced by large dose administration of amphetamine. J Psychedel Drugs 2: 42–48, 1969.Google Scholar
  3. 3.
    Inaba D, Way EL, Blum K, Schnoll SH: Pharmacological and toxicological perspectives on commonly abused drugs. Med Monogr Ser 1: 70–140, 1978.Google Scholar
  4. 4.
    Jaffe JH: Drug addiction and drug abuse. In Gilman AG, et al. (eds): The pharmacological basis of therapeutics. Macmillan, New York, 1980.Google Scholar
  5. 5.
    Jacobs JE: Emergency room drug abuse treatment. J Psychedel Drugs 7: 43–48, 1975.Google Scholar
  6. 6.
    Meyers FH: A review of medical pharmacology. Lang Medical Publications, Los Altos, 1968.Google Scholar
  7. 7.
    Schick JFE, Freedman DX: Research in non-narcotic drug abuse. In Arieta S (ed): American handbook of psychiatry: new psychiatric frontiers, 2nd ed., vol. 6 Basic Books, Inc, New York, 1975.Google Scholar
  8. 8.
    Schick JFE, Smith DE, Meyers FH: Patterns of drug use in the Haight Ashbury neighborhood. Clin Toxicol 3: 123–131, 1970.Google Scholar
  9. 9.
    Schick JFE, Smith DE, Wesson DR: Analysis of amphetamine toxicity and patterns of use. J Psychedel Drugs 5: 113–130, 1972.Google Scholar
  10. 10.
    Spira JD, Cherubin CE: Drug abuse: a guide for the clinician. In Excerpta medica, vol. 109, 1974.Google Scholar
  11. 11.
    Schuckit MA: Drug and alcohol abuse: a clinical guide to diagnosis and treatment. Plenum Medical Book Co, New York, 1979.Google Scholar
  12. 12.
    Seymour RB, Gorton JG, Smith DE: The client with a substance abuse problem. In Gorton JG, Partridge R (eds): Practice and management of psychiatric emergency room care. C. V. Mosby Co, St. Louis, 1982.Google Scholar
  13. 13.
    Siegel RK: Cocaine smoking monograph issue. J Psychoact Drugs 14: 271–355, 1982.Google Scholar
  14. 14.
    Smith DE, Anderson SM, Buxton M, Gottlieb N, Harvey W, Chung T (eds): A multicultural view of drug abuse. G.K. Hall & Co/Schenkman Publishing Co, Inc, Cambridge, 1978.Google Scholar
  15. 15.
    Smith DE, Wesson DR: Low dose benzodiazepine withdrawal: receptor site mediated. Newsletter of California Society for the Treatment of Alcoholism and Other Drug Dependencies. San Francisco, vol. 1, 1982.Google Scholar
  16. 16.
    Smith DE, Seymour RB: Prescribing psychoactive drugs: a question of perspective.” In Morgan JP, Kagan DV (eds): Society and medication: conflicting signals for prescribers and patients. Lexington Books, Lexington, 1983.Google Scholar
  17. 17.
    Smith DE, Wesson DR, Seymour RB: The abuse of barbiturates and other sedative-hypnotics. In Du Pont, et al. (eds): Handbook on drug abuse. Basic Books, New York, 1979.Google Scholar
  18. 18.
    Synder SH: Amphetamine psychosis: a “model” schizophrenic medicated by catecholamines. Am J Psych 130: 74–121, 1973.Google Scholar
  19. 19.
    Wesson DR, Smith DE: A clinical approach to the diagnosis and treatment of amphetamine abuse. In Smith DE, et al. (eds): Amphetamine use, misuse and abuse. Proceedings of the National Amphetamine Conference. G.K. Hall & Co, Boston, 1978.Google Scholar
  20. 20.
    Wesson DR, Smith DE, Linda KL: Drug crisis intervention: conceptual and pragmatic considerations. J Psychedel Drugs 6: 135–142, 1974.Google Scholar
  21. 21.
    Wesson DR, Ling W: Naltrexone and its use in treatment of opiate dependent physicians. Newsletter of California Society for the Treatment of Alcoholism and Other Drug Dependencies, vol. 7, 1980.Google Scholar
  22. 22.
    Wilford BB (ed): Drug abuse—a guide for the primary care physician. American Medical Association, Chicago, 1981.Google Scholar
  23. 23.
    Williams MH: Drugs and athletic performance. Charles C. Thomas, Springfield, 1973.Google Scholar
  24. 24.
    Whitfield DC, Smith DE, Seymour RB: Psychedelics. In Whitfield DS (ed): The patient with alcoholism and other drug problems, a clinical approach for physicians and helping professionals. Year Book Medical Publishers, Inc, Chicago, 1980.Google Scholar
  25. 25.
    Senay EC: Substance abuse disorders in clinical practice. John Wright PSG, Inc, Boston, 1983.Google Scholar

Copyright information

© Springer-Verlag New York Inc. 1986

Authors and Affiliations

  • David E. Smith
  • Richard B. Seymour

There are no affiliations available

Personalised recommendations